Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: Frequent late relapses but good overall survival

British Journal of Haematology

Volumn 140, Issue 6, 2008, Pages 665-672

  Forestier, Erik ^a   Heyman, Mats ^b   Andersen, Mette K ^c   Autio, Kirsi ^d   Blennow, Elisabeth ^e   Borgström, Georg ^d   Golovleva, Irina ^a   Heim, Sverre ^f,g   Heinonen, Kristina ^h   Hovland, Randi ⁱ   Johannsson, Johann H ^j   Kerndrup, Gitte ^k   Nordgren, Ann ^e   Rosenquist, Richard ^l   Swolin, Birgitta ^m   Johansson, Bertil ⁿ  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c University of Copenhagen   (Denmark)

^d UNIVERSITY OF HELSINKI   (Finland)

^e KAROLINSKA INSTITUTE   (Sweden)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF OSLO   (Norway)

^h KUOPIO UNIVERSITY HOSPITAL   (Finland)

ⁱ HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^j LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^k ODENSE UNIVERSITY HOSPITAL   (Denmark)

^l UPPSALA UNIVERSITY   (Sweden)

^m SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

ⁿ LUND UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Acute lymphoblastic leukaemia; Childhood; ETV6 RUNX1; Prognosis; Relapse; t(12; 21)(p13; q22)

Indexed keywords

TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER REGRESSION; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 21; CLINICAL PROTOCOL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FEMALE; HUMANS; INFANT; MALE; ONCOGENE PROTEINS, FUSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSLOCATION, GENETIC;

EID: 39749177335     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.06980.x     Document Type: Article

References (53)

1. Alessandri, A.J., Reid, G.S.D., Bader, S.A., Massing, B.G., Sorensen, P.H.B. Schultz, KR. (2002) ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotype. British Journal of Haematology, 116, 266 272.
2. Al-Sweedan, S.A., Neglia, J.P., Steiner, M.E., Bostrom, B.C., Casey, T. Hirsch, B.A. (2007) Characteristics of patients with TEL-AML1-positive acute lymphoblastic leukemia with single or multiple fusions. Pediatric Blood & Cancer, 48, 510 514.
3. Alvarez, Y., Coll, M.D., Ortega, J.J., Bastida, P., Dastugue, N., Robert, A., Cervera, J., Verdeguer, A., Tasso, M., Aventin, A., Guitart, M. Caballin, M.R. (2005) Genetic abnormalities associated with the t(12;21) and their impact in the outcome of 56 patients with B-precursor acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics, 162, 21 29.
4. Attarbaschi, A., Mann, G., König, M., Dworzak, M.N., Trebo, M.M., Mühlegger, N., Gadner, H. Haas, O.A. (2004) Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1 + acute lymphoblastic leukemia: an interphase FISH analysis. Leukemia, 18, 1611 1616.
5. Avigad, S., Kuperstein, G., Zilberstein, J., Liberzon, E., Stark, B., Gelernter, I., Kodman, Y., Luria, D., Ash, S., Stein, J., Goshen, Y., Yaniv, I., Cohen, I.J. Zaizov, R. (1999) TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia. Leukemia, 13, 481 483.
6. Baruchel, A., Cayuela, J.M., Ballerini, P., Landman-Parker, J., Cezard, V., Firat, H., Haddad, E., Auclerc, M.F., Valensi, F., Cayre, Y.E., Macintyre, E.A. Sigaux, F. (1997) The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts. British Journal of Haematology, 99, 101 106.
7. Borkhardt, A., Cazzaniga, G., Viehmann, S., Valsecchi, M.G., Ludwig, W.D., Burci, L., Mangioni, S., Schrappe, M., Riehm, H., Lampert, F., Basso, G., Masera, G., Harbott, J. Biondi, A. (1997) Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood, 90, 571 577.
8. Borowitz, M.J., Rubnitz, J., Nash, M., Pullen, D.J. Camitta, B. (1998) Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study. Leukemia, 12, 1764 1770.
9. Codrington, R., O'Connor, H.E., Jalali, G.R., Carrara, P., Papaioannou, M., Hart, S.M., Hoffbrand, A.V., Potter, M., Prentice, H.G., Harrison, C.J. Foroni, L. (2000) Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value. British Journal of Haematology, 111, 1071 1079.
10. De Zen, L., Orfao, A., Cazzaniga, G., Masiero, L., Cocito, M.G., Spinelli, M., Rivolta, A., Biondi, A., Zanesco, L. Basso, G. (2000) Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification. Leukemia, 14, 1225 1231.
11. Endo, C., Oda, M., Nishiuchi, R. Seino, Y. (2003) Persistence of TEL-AML1 transcript in acute lymphoblastic leukemia in long-term remission. Pediatrics International, 45, 275 280.
12. Ford, A.M., Fasching, K., Panzer-Grümayer, E.R., Koenig, M., Haas, O.A. Greaves, M.F. (2001) Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. Blood, 98, 558 564.
13. Forestier, E. Schmiegelow, K. (2006) The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations. Journal of Pediatric Hematology/Oncology, 28, 486 495.
14. Forestier, E., Andersen, M.K., Autio, K., Blennow, E., Borgström, G., Golovleva, I., Heim, S., Heinonen, K., Hovland, R., Johannsson, J.H., Kerndrup, G., Nordgren, A., Rosenquist, R., Swolin, B. Johansson, B. (2007) Cytogenetic patterns in ETV6/RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia: a Nordic series of 245 cases and review of the literature. Genes, Chromosomes and Cancer, 46, 440 450.
15. Frost, B.M., Forestier, E., Gustafsson, G., Nygren, P., Hellebostad, M., Jonsson, O.G., Kanerva, J., Schmiegelow, K., Larsson, R. Lönnerholm, G. (2004) Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia. Blood, 104, 2452 2457.
16. Golub, T.R., Barker, G.F., Bohlander, S.K., Hiebert, S.W., Ward, D.C., Bray-Ward, P., Morgan, E., Raimondi, S.C., Rowley, J.D. Gilliland, D.G. (1995) Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 92, 4917 4921.
17. Gustafsson, G., Schmiegelow, K., Forestier, E., Clausen, N., Glomstein, A., Jonmundsson, G., Mellander, L., Mäkipernaa, A., Nygaard, R. Saarinen-Pihkala, U.M. (2000) Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia, 14, 2267 2275.
18. de Haas, V., Oosten, L., Dee, R., Verhagen, O.J.H.M., Kroes, W., van den Berg, H. van der Schoot, C.E. (2000) Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia. British Journal of Haematology, 111, 1080 1086.
19. Hann, I., Vora, A., Harrison, G., Harrison, C., Eden, O., Hill, F., Gibson, B. Richards, S. (2001) Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. British Journal of Haematology, 113, 103 114.
20. Harbott, J., Viehmann, S., Borkhardt, A., Henze, G. Lampert, F. (1997) Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood, 90, 4933 4937.
21. Hubeek, I., Ramakers-van Woerden, N.L., Pieters, R., Slater, R., Beverloo, H.B., van Wering, E.R., Kamps, W., Hählen, K. Veerman, A.J.P. (2001) TEL/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukaemia. British Journal of Haematology, 113, 254 255.
22. Jamil, A., Theil, K.S., Kahwash, S., Ruymann, F.B. Klopfenstein, K.J. (2000) TEL/AML-1 fusion gene: its frequency and prognostic significance in childhood acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics, 122, 73 78.
23. Karrman, K., Forestier, E., Andersen, M.K., Autio, K., Borgström, G., Heim, S., Heinonen, K., Hovland, R., Kerndrup, G. Johansson, B. (2006) High incidence of the ETV6/RUNX1 fusion gene in paediatric precursor B-cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: a Nordic series of cases diagnosed 1989-2005. British Journal of Haematology, 135, 352 354.
24. Kempski, H., Chalker, J., Chessells, J., Sturt, N., Brickell, P., Webb, J., MacDonald Clink, J. Reeves, B. (1999) An investigation of the t(12;21) rearrangement in children with B-precursor acute lymphoblastic leukaemia using cytogenetic and molecular methods. British Journal of Haematology, 105, 684 689.
25. Konrad, M., Metzler, M., Panzer, S., Östreicher, I., Peham, M., Repp, R., Haas, O.A., Gadner, H. Panzer-Grümayer, E.R. (2003) Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone. Blood, 101, 3635 3640.
26. Lanza, C., Volpe, G., Basso, G., Gottardi, E., Barisone, E., Spinelli, M., Ricotti, E., Cilli, V., Perfetto, F., Madon, E. Saglio, G. (1997) Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia. British Journal of Haematology, 97, 460 462.
27. Loh, M.L., Silverman, L.B., Young, M.L., Neuberg, D., Golub, T.R., Sallan, S.E. Gilliland, D.G. (1998) Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia. Blood, 92, 4792 4797.
28. Loh, M.L., Goldwasser, M.A., Silverman, L.B., Poon, W.-M., Vattikuti, S., Cardoso, A., Neuberg, D.S., Shannon, K.M., Sallan, S.E. Gilliland, D.G. (2006) Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01. Blood, 107, 4508 4513.
29. Ma, S.K., Wan, T.S.K., Cheuk, A.T.C., Fung, L.F., Chan, G.C.F., Chan, S.Y., Ha, S.Y. Chan, L.C. (2001) Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: a molecular cytogenetics study. Leukemia, 15, 1442 1447.
30. Maloney, K.W., McGavran, L., Murphy, J.R., Odom, L.F., Stork, L., Wei, Q. Hunger, S.P. (1999) TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification. Leukemia, 13, 1708 1712.
31. McLean, T.W., Ringold, S., Neuberg, D., Stegmaier, K., Tantravahi, R., Ritz, J., Koeffler, H.P., Takeuchi, S., Janssen, J.W.G., Seriu, T., Bartram, C.R., Sallan, S.E., Gilliland, D.G. Golub, T.R. (1996) TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood, 88, 4252 4258.
32. Metzler, M., Mann, G., Monschein, U., Lodzinski, M., Gall, C., Flohr, T., Viehmann, S., Langer, T., Schrappe, M., Gadner, G., Haas, O.A. Panzer-Grümayer, E.R. (2006) Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: comparison of Ig/TCR rearrangements and the genomic fusion gene. Haematologica, 91, 683 686.
33. Nakao, M., Yokota, S., Horiike, S., Taniwaki, M., Kashima, K., Sonoda, Y., Koizumi, S., Takaue, Y., Matsushita, T., Fujimoto, T. Misawa, S. (1996) Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia, 10, 1463 1470.
34. Pajor, L., Lacza, Á., Jáksó, P. Kajtár, B. (2001) Characteristics of TEL/AML-1 positive acute lymphoblastic leukemia in Hungarian children. Medical and Pediatric Oncology, 37, 409 411.
35. Peham, M., Konrad, M., Harbott, J., König, M., Haas, O.A. Panzer-Grümayer, E.R. (2004) Clonal variation of the immunogenotype in relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development. Genes, Chromosomes and Cancer, 39, 156 160.
36. Rafi, S.K., El Gebaly, H. Qumsiyeh, M.B. (2000) ETV6/CBFA2 fusions in childhood B-cell precursor acute lymphoblastic leukemia with myeloid markers. Diagnostic Molecular Pathology, 9, 184 189.
37. Ramakers-van Woerden, N.L., Pieters, R., Loonen, A.H., Hubeek, I., van Drunen, E., Beverloo, H.B., Slater, R.M., Harbott, J., Seyfarth, J., van Wering, E.R., Hahlen, K., Schmiegelow, K., Janka-Schaub, G.E. Veerman, A.J. (2000) TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood, 96, 1094 1099.
38. Raynaud, S.D., Dastugue, N., Zoccola, D., Shurtleff, S.A., Mathew, S. Raimondi, S.C. (1999) Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia. Leukemia, 13, 1325 1330.
39. Romana, S.P., Le Coniat, M. Berger, R. (1994) t(12;21): a new recurrent translocation in acute lymphoblastic leukemia. Genes, Chromosomes and Cancer, 9, 186 191.
40. Romana, S.P., Mauchauffé, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R. Bernard, O.A. (1995a) The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood, 85, 3662 3670.
41. Romana, S.P., Poirel, H., Leconiat, M., Flexor, M.-A., Mauchauffé, M., Jonveaux, P., Macintyre, E.A., Berger, R. Bernard, O.A. (1995b) High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood, 86, 4263 4269.
42. Rubnitz, J.E., Shuster, J.J., Land, V.J., Link, M.P., Pullen, D.J., Camitta, B.M., Pui, C.-H., Downing, J.R. Behm, F.G. (1997) Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study. Blood, 89, 1143 1146.
43. Rubnitz, J.E., Behm, F.G., Wichlan, D., Ryan, C., Sandlund, J.T., Ribeiro, R.C., Rivera, G.K., Hancock, M.L., Relling, M.V., Evans, W.E., Pui, C.-H. Downing, J.R. (1999) Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup. Leukemia, 13, 19 21.
44. Satake, N., Kobayashi, H., Tsunematsu, Y., Kawasaki, H., Horikoshi, Y., Koizumi, S. Kaneko, Y. (1997) Minimal residual disease with TEL-AML1 fusion transcript in childhood acute lymphoblastic leukaemia with t(12;21). British Journal of Haematology, 97, 607 611.
45. Seeger, K., Adams, H.-P., Buchwald, D., Beyermann, B., Kremens, B., Niemeyer, C., Ritter, J., Schwabe, D., Harms, D., Schrappe, M. Henze, G. (1998) TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. Blood, 91, 1716 1722.
46. Seeger, K., Buchwald, D., Taube, T., Peter, A., von Stackelberg, A., Schmitt, G., Köchling, J. Henze, G. (1999) TEL-AML1 positivity in relapsed B cell precursor acute lymphoblastic leukemia in childhood. Leukemia, 13, 1469 1470.
47. Seeger, K., Kreuzer, K.-A., Lass, U., Taube, T., Buchwald, D., Eckert, C., Körner, G., Schmidt, C.-A. Henze, G. (2001) Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction. Cancer Research, 61, 2517 2522.
48. Shurtleff, S.A., Buijs, A., Behm, F.G., Rubnitz, J.E., Raimondi, S.C., Hancock, M.L., Chan, G.C.-F., Pui, C.-H., Grosveld, G. Downing, J.R. (1995) TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia, 9, 1985 1989.
49. Takahashi, Y., Horibe, K., Kiyoi, H., Miyashita, Y., Fukuda, M., Mori, H., Nozaki, C., Hasegawa, S., Kawabe, T., Kato, K., Kojima, S., Matuyama, T. Naoe, T. (1998) Prognostic significance of TEL/AML1 fusion transcript in childhood B-precursor acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology, 20, 190 195.
50. Tsang, K.S., Li, C.K., Chik, K.W., Shing, M.M.K., Tsoi, W.C., Ng, M.H.L., Lau, T.T., Leung, Y. Yuen, P.M.P. (2001) TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong. American Journal of Hematology, 68, 91 98.
51. Uckun, F.M., Pallisgaard, N., Hokland, P., Navara, C., Narla, R., Gaynon, P.S., Sather, H. Heerema, N. (2001) Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia. Leukemia and Lymphoma, 42, 41 56.
52. Zuna, J., Hrušák, O., Kalinová, M., Mužíková, K., Starý, J. Trka, J. (1999) Significantly lower relapse rate for TEL/AML1-positive ALL. Leukemia, 13, 1633.
53. Zuna, J., Ford, A.M., Peham, M., Patel, N., Saha, V., Eckert, C., Köchling, J., Panzer-Grümayer, R., Trka, J. Greaves, M. (2004) TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia. Clinical Cancer Research, 10, 5355 5360.